Navigation Links
Phase I/II-data on Systemic Application of the TGF-beta2-inhibitor,AP 12009 to be Presented

The agents specifically block the synthesis of key cancer proteins. The lead product AP 12009 is targeting Transforming Growth Factor-beta2 (TGF-beta2), a crucial factor that promotes tumor progression via multiple pathomechanisms. AP 12009 is in advanced clinical development for the treatment of high-grade glioma as well as in Phase I/II clinical trial for various other solid tumors. The further product pipeline covers preclinical drug candidates as well as compounds in research and discovery. Antisense Pharma has been honored with the Bavarian Innovation Award and the German Founders Award.

This document contains forward-looking statements with respect to the future business of Antisense Pharma GmbH. By their nature, forward-looking statements and forecasts involve risks and uncertainties because they relate to events and depend on circumstances that could occur in the future. There is a number of factors that could cause actual results and developments to differ materially. Antisense Pharma GmbH disclaims any intent of obligation to update any of these forward-looking statements.

For further information please contact:

ANTISENSE PHARMA GmbH

Dr. Heike Specht / Public Relations
Josef-Engert-Str. 9, D-93053 Regensburg
Phone: +49-941-92013-0
Fax: +49-941-92013-29
e-mail: pr@antisense-pharma.com
www.antisense-pharma.com


'"/>




Page: 1 2

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
7. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
8. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
9. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
10. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Phase data Systemic Application the TGF beta2 inhibitor Presented
(Date:11/24/2009)...FirstCall/--NeurogesX,Inc.(Nasdaq: NGSX ),abiophar...zingnovelpainmanagementtherapies,todayannouncedthe...ctiveNovember19,2009.Mr.Orwinisa20-yearsalesandmar...eeninstrumentalinthelaunchofseveralimportanttherap...resident,BioOncologyBusinessUnitatGenentech,Inc.,a...
(Date:11/23/2009)...heChicagoarea,sleadingBoardCertifiedDiagnosticRadi...g,couplingthelatesttechnologyindigitalmammography,...havethefullrangeofdigitalimagingcompleted,diagnose...e.Drs.AhmedFaragandJoanWerberaredeliveringthispati...foranappointmentcommonlyfoundinChicago,fromtheirne...
(Date:11/23/2009)...stCall/--Immucor,Inc.(Nasdaq: BLUD ),agloballeader...bloodtransfusionindustry,todayannouncedthataccesst...areConferenceinNewYork,NYwillbeavailableviaalive,s...isscheduledforTuesday,December1,2009,at12:30p.m.Ea...roughthe"AboutUs--InvestorInformation"sectionatwww...
Breaking Medicine Technology:NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board Director 2NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board Director 3Boys May Feel a Genetic Pull Toward Gangs 49195 1Boys May Feel a Genetic Pull Toward Gangs 49195 2Elsevier Honored as 22The Most Influential Publisher of the Last 100 Years in BioMedicine and the Life Sciences 22 by the Special Libraries Associati 49192 1Elsevier Honored as 22The Most Influential Publisher of the Last 100 Years in BioMedicine and the Life Sciences 22 by the Special Libraries Associati 49192 2Elsevier Honored as 22The Most Influential Publisher of the Last 100 Years in BioMedicine and the Life Sciences 22 by the Special Libraries Associati 49192 3Elsevier Honored as 22The Most Influential Publisher of the Last 100 Years in BioMedicine and the Life Sciences 22 by the Special Libraries Associati 49192 4Accurays Euan Thomson Named Ernst 26 Young Entrepreneur Of The Year 28R 29 2009 Award Recipient in Northern California 49189 1Accurays Euan Thomson Named Ernst 26 Young Entrepreneur Of The Year 28R 29 2009 Award Recipient in Northern California 49189 2Accurays Euan Thomson Named Ernst 26 Young Entrepreneur Of The Year 28R 29 2009 Award Recipient in Northern California 49189 3
...re Programs Automate the Interface between Health ... Customized Care Treatment Plans, AUBURN, Calif.,... leader in the development of medical management s...TM) (ACUITY), announced today,that it has released...as,the AcuCare Programs (AcuCare). The three new A...
... FDA Approval, Company Announces $7,800 Wholesale ...ug, LOS ANGELES, Jan. 21 AIDS Healthcare,Foundat..., a division of,Johnson & Johnson, to reconsider a..., etravirine (TMC 125), a non-nucleoside reverse t...od and Drug Administration (FDA),approval on Frida...
Other Medicine Technology:TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY 2TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY 3AHF Criticizes Tibotec Over Steep Price for Newest AIDS Drug, Etravirine 2AHF Criticizes Tibotec Over Steep Price for Newest AIDS Drug, Etravirine 3
(Date:11/24/2009)...nancials,S-1RegistrationStatementbeingPreparedbyLe...STON,Fla.,Nov.24/PRNewswire-FirstCall/--AmericanSc...")ispleasedtomakeavailableacurrentcorporateupdate....nksheetsrecently,ASRhasbeendiligentinaccomplishing...planfortheCompany. ,, Aspartofthisongoingproces...
(Date:11/24/2009)...Ga.,Nov.24/PRNewswire-FirstCall/--AflacIncorporate...upplchasacceptedtheexchangeoftwoofitsinvestmentsec...uncedbyLloydsonNovember3,2009,andtheexchangesareex...actionsettles,Aflacwillhaveexchangeditsinvestmenti...ualsecurities(parvalueof$222millionatSeptember30,2...
(Date:11/24/2009)...EK,Mich.,Nov.24/PRNewswire-USNewswire/--Thefollowi...dCEOoftheW.K.KelloggFoundation: ,, TheW.K.Kello...urgentneedtocomprehensivelyandsubstantiallystrengt..., Mostrecently,theSenateversionofhealthreformrepr...orethantwodozenimportantprovisionsaimedatimproving...
(Date:11/24/2009)...d with online predators, but few fear cyberbullyin...althDay News) -- More than four in five parents sa...pervision, but at the same time almost two-thirds ...as found. , The findings, released online Nov. ...oll on Children,s Health, show that parents have a...
(Date:11/24/2009)...cience is behind reasoning that testing less is OK...- The world of cancer screening has been upended i...reventive Services Task Force (USPSTF) just raise ...st mammogram from 40 to 50, but the American Colle...that adolescents should be spared the inconvenienc...
Breaking Medicine News(10 mins):Health News:American Scientific Resources Inc. Issues Corporate Update 2Health News:American Scientific Resources Inc. Issues Corporate Update 3Health News:Aflac To Exchange Two Lloyds Banking Group Securities, Enhance Risk-Based Capital Ratio 2Health News:Aflac To Exchange Two Lloyds Banking Group Securities, Enhance Risk-Based Capital Ratio 3Health News:Aflac To Exchange Two Lloyds Banking Group Securities, Enhance Risk-Based Capital Ratio 4Health News:Statement of Support: Strengthening Oral Health Care is Key Part of Health Reform 2Health News:Parents Worry About Their Kids' Safety on the Internet 2Health News:Recent Cancer Screening Changes Leave Many Confused 2Health News:Recent Cancer Screening Changes Leave Many Confused 3Health News:Recent Cancer Screening Changes Leave Many Confused 4
...ng ABC Plan; Urges Senate to,Act Quickly, HARRISB...ay praised the House of Representatives for taking...ia Access to Basic Care (PA ABC) plan,and he urged...o help physicians pay their medical malpractice,in...
...mines Racial Health,Disparities, WHITE PLAINS, N....y rate is more than twice as high as white,America...aged 17.6 percent,compared to the national average...s." This episode, scheduled,to air Thursday, April...
...d with colorectal cancer, has been attributed to b...hat the anti-microbial peptide hepcidin can also i... inflammation. This type of anaemia has been terme...logy was to address whether a component of the ana...
...ns play an important role in the lives of humans, ...nd interactions. The ability to regulate emotions...ng. Conversely, difficulties with emotion regulat...ychiatry on March 15th. Thus, these researchers s...
...; Improves Lives, WASHINGTON, March 18 Seniors o...giography and arterial interventions --,such as va...well as younger,patients. A study released today d...oided surgery and could be,treated as outpatients ...
...n Significantly Lower Infection ...cerns about the,rising incidence of methicillin-re...ve prompted lawmakers in a number of states around...n,patients for MRSA upon admission and similar pro...
Other Medicine News:Health News:Governor Rendell Says Pennsylvania is One Step Closer to Providing Access to Health Care for Pennsylvania's Uninsured 2Health News:Governor Rendell Says Pennsylvania is One Step Closer to Providing Access to Health Care for Pennsylvania's Uninsured 3Health News:Black Infants Are More Likely to Be Born Preterm and to Die at Birth 2Health News:The regulation of negative emotions: Impact on brain activity 2Health News:Safe at Any Age: Octogenarians Do As Well as Younger Patients With Interventional Radiology Arterial Procedures 2Health News:Safe at Any Age: Octogenarians Do As Well as Younger Patients With Interventional Radiology Arterial Procedures 3Health News:More States Move to Require Hospitals to Screen Patients for MRSA 2Health News:More States Move to Require Hospitals to Screen Patients for MRSA 3Health News:More States Move to Require Hospitals to Screen Patients for MRSA 4
...ne, produced in the adrenal gland and gonads, is t...trone, both of which may be subsequently converted... androgenic activity, estimated at ~(less than or ...androstenedione levels often exceed testosterone i...
...heterodimeric proteins that suppress the secretion...tuitary. Inhibin consists of two distinct chains, ...ibin A consists of the alpha-subunit and betaA-sub...betaB-subunit. Only the dimeric forms of the molec...
...growth factor II (IGF-II) is a 7.5 kDa peptide whi...lated to have mitogenic and metabolic actions invo... mediated by binding to target cell receptors. IGF...ceptor, a monomeric protein which also serves as t...
...roteohormone with a molecular weight of 16 kDa. L...uced by adipocytes [1,2]. Leptin is thought to pl...3]. In the human, leptin levels are elevated with...A relationship between serum leptin levels and sev...
Medicine Products: